Sort
30,917 grants matching “tumor microenvironment”
Improving the Efficacy of Dendritic Cell Vaccines
$999,999Jacques F Banchereau · Baylor Research Institute · P01 · FY2006 · CA
Development and Validation of a Collaborative Web/Cloud-Based Dosimetry System for Radiopharmaceutical Therapy.
$999,998Michael Ghaly · Radiopharmaceutical Imaging And Dosimetry, Llc · R44 · FY2019 · CA
Development of GIFT4: a B cell focused immunotherapy for cancer
$999,997Paul Guyre · Celdara Medical, Llc · R44 · FY2018 · CA
Thyroid Cancer Aggressiveness in WTC Responders
$999,987Emanuela Taioli · Icahn School Of Medicine At Mount Sinai · U01 · FY2020 · OH
Thyroid Cancer Aggressiveness in WTC Responders
$999,774Emanuela Taioli · Icahn School Of Medicine At Mount Sinai · U01 · FY2019 · OH
Reprogramming the Tumor-Immune Interface in Oral Cancer
$999,772John B Sunwoo · Stanford University · R35 · FY2022 · DE
Induction of an Antitumor Immune Response in Patients with Melanoma
$999,555Patrick Hwu · University Of Tx Md Anderson Can Ctr · P50 · FY2011 · CA
Instantaneous Tumor Spray for Real-Time Surgical Guidance
$999,432Brian David Gray · Molecular Targeting Technologies, Inc. · R44 · FY2023 · CA
Instantaneous Tumor Spray for Real-Time Surgical Guidance
$999,389Brian David Gray · Molecular Targeting Technologies, Inc. · R44 · FY2022 · CA
PyroTIMER Technology: Enabling T-Cell Persistence in Immunosuppressive Tumor Microenvironments
$999,283Archis Bagati · Pyrojas Inc · R44 · FY2025 · CA
Development of GIFT4: a B cell focused immunotherapy for cancer
$999,088Paul Guyre · Celdara Medical, Llc · R44 · FY2017 · CA
Development of Small Molecule Inhibitors and Biologic Agents for Treatment of Glioblastoma Using Intracerebral Microdialysis and Signatures of Vulnerability
$999,063Jana Portnow · Beckman Research Institute/City Of Hope · U19 · FY2021 · CA
Development of CD4 TCR-engineered T cell immunotherapy in triple-negative breast cancer
$998,971Yicheng Wang · Immunova Therapeutics, Llc · R44 · FY2025 · CA
Liquid Immunotherapeutic Fiducial Eluter (LIFE) Gel for Cervical Cancer
$998,781Adam Shilling · Nanocan Therapeutics Corporation · R42 · FY2025 · CA
Optimization of a clinical stage nanoparticle drug delivery platform
$998,609Bob D. Brown · Dicerna Pharmaceuticals, Inc. · R44 · FY2017 · CA
Spatial genomics analysis of tumor samples
$998,481Kirsten Frieda · Spatial Genomics, Inc. · R44 · FY2023 · CA
Spatial genomics analysis of tumor samples
$998,481Kirsten Frieda · Spatial Genomics, Inc. · R44 · FY2024 · CA
Induction of an Antitumor Immune Response in Patients with Melanoma
$998,246Patrick Hwu · University Of Tx Md Anderson Can Ctr · P50 · FY2014 · CA
Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer
$997,515Valerie Humblet · Collagen Medical, Llc · R44 · FY2016 · CA
Precision microRNA medicine in cancer
$997,500Frank J. Slack · Beth Israel Deaconess Medical Center · R35 · FY2024 · CA
All-Human Microphysical Model of Metastasis Therapy
$996,993Linda G. Griffith · Massachusetts Institute Of Technology · UH3 · FY2016 · TR
Identifying Metabolic Dependencies of Pancreatic Cancers
$996,661Alec Kimmelman · New York University School Of Medicine · R35 · FY2022 · CA
Identifying Metabolic Dependencies of Pancreatic Cancers
$996,661Alec Kimmelman · New York University School Of Medicine · R35 · FY2023 · CA
Systemic regulation of metastasis
$996,660David Charles Lyden · Weill Medical Coll Of Cornell Univ · R35 · FY2022 · CA
Molecular mechanisms of antibody-mediated immunotherapies
$996,658Jeffrey Victor Ravetch · Rockefeller University · R35 · FY2022 · CA